Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

1716232 Title: ZURE ALFA-GLUCOSIDASE EN FRAGEMENTEN DAARVAN

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
057133100
WO application number:
US2005004286
Type:
European patent granted for BE
Status:
Expired
Publication number:
1716232
WO publication number:
WO 2005/078077
1rst applicant's nationality:
Translation language:
Dutch
EPO publication language:
English
SPC number:

Dates

Filing date:
10/02/2005
Grant date:
21/04/2010
EP publication date:
WO publication date:
Claims translation received date:
Translation received date (EP publication B1):
21/07/2010
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
21/04/2010
EP B1 publication date:
21/04/2010
EP B2 publication date:
EP B3 publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):
10/02/2025

Applicant

1

Name:
BioMarin Pharmaceutical, Inc.
Legal Form:
From:
20/05/2011
Address:
105 Digital Drive, Novato CA 94949, United States (US)
To:

2

Name:
ZYSTOR THERAPEUTICS INC.
Legal Form:
From:
21/04/2010
Address:
-, -, Unknown (UNKNOWN)
To:
20/05/2011

Agent

Name:
HOEBEN Ferdinand Egon
Legal Form:
From:
21/07/2010
Address:
Postbus 1551, 1200 BN, Hilversum, Netherlands (NL)
To:

Inventor

1

Name:
LEBOWITZ, Jonathan
Legal Form:
Address:

2

Name:
MAGA, John
Legal Form:
Address:

Priority

Priority patent number:
543812
Priority date:
10/02/2004
Priority country:
United States (US)

Classification

Main IPC class:
C12N 9/24;

Publication

Bulletin

1

Bulletin heading:
EP2
Journal edition number:
2010/04
Publication date:
30/04/2010
Description:
Contains data concerning European patents granted and published (B1 publication) for Belgium and for which no translation needed to be filed

2

Bulletin heading:
VRV
Journal edition number:
2025/03
Publication date:
01/05/2025
Description:
Contains data concerning lapse, annulment or rejection of patent(s) (applications) and SPC (applications)

Annual fee

Annual fee(s) Due Date:
Annual fee number:
Expected payer:
Last annual fee payment date:
23/01/2024
Last annual fee paid number:
20
Last annual fee paid amount:
600 Euro
Payer:
ANAQUA SERVICES
Filing date Document type Publication Type Document Description Number of pages File Type
21/07/2010 General Document (F - F:Traduction déposée par fax) 64 PDF /2/3/2/6/1/0611716232/migrated-docs/057133100_1_261967.pdf
26/07/2010 General Document (OF - T:Traduction Originale de la traduction déposée par fax) 64 PDF /2/3/2/6/1/0611716232/migrated-docs/057133100_2_261967.pdf
16/05/2011 General Document (CS - S:Cession) 16 PDF /2/3/2/6/1/0611716232/migrated-docs/057133100_3_261967.pdf